These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27362901)

  • 41. [Prognostic significance of morphological parameters in malignant epithelial ovarian tumors].
    Breitenecker G; Bartl W; Scheiber V
    Pathologe; 1983 Jan; 4(1):29-40. PubMed ID: 6302656
    [No Abstract]   [Full Text] [Related]  

  • 42. [Ovarian endometriosis].
    Karseladze AI
    Arkh Patol; 1990; 52(9):24-9. PubMed ID: 2270976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ovarian mucinous borderline tumors of intestinal type without intraepithelial carcinoma: are they still tumors of low malignant potential?
    Nomura K; Aizawa S; Hano H
    Pathol Int; 2004 Jun; 54(6):420-4. PubMed ID: 15144401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epithelial metaplastic changes in ovarian endometriosis.
    Fukunaga M; Ushigome S
    Mod Pathol; 1998 Aug; 11(8):784-8. PubMed ID: 9720509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Relationship between malignant transformation of ovarian mucinous cystadenoma and intestinal epithelial metaplasia].
    Zhong CQ
    Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):134-6. PubMed ID: 2555075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ovarian seromucinous cystadenomas and adenofibromas: first report of a case series.
    Ben-Mussa A; McCluggage WG
    Histopathology; 2021 Feb; 78(3):445-452. PubMed ID: 32810322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
    Jordan SJ; Green AC; Whiteman DC; Webb PM;
    Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endocervical-like versus intestinal-type mucinous borderline ovarian tumors: a large retrospective series focusing on the clinicopathologic characteristics.
    Song T; Choi CH; Lee YY; Kim TJ; Lee JW; Sung CO; Song SY; Bae DS; Kim BG
    Gynecol Obstet Invest; 2013; 76(4):241-7. PubMed ID: 24192519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinicopathologic analysis of ovarian serous and mucinous borderline tumors].
    Zhong C; Yu X; Zhang J; Wei B; Luo B; Sun L; Zhang N; Fu Q
    Zhonghua Bing Li Xue Za Zhi; 2001 Aug; 30(4):253-5. PubMed ID: 11758211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Histopathologic status as a prognostic factor in ovarian cancer].
    Schieder K; Breitenecker G; Köbl H; Bieglmayer C
    Gynakol Rundsch; 1990; 30 Suppl 1():147-50. PubMed ID: 1964147
    [No Abstract]   [Full Text] [Related]  

  • 52. Emergence of CA125 immunoreactivity in recurrent or metastatic primary ovarian mucinous neoplasms of the intestinal type.
    Miller K; Millar J; McCluggage WG
    Am J Surg Pathol; 2011 Sep; 35(9):1331-6. PubMed ID: 21836488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intestinal type and endocervical-like ovarian mucinous neoplasms are immunophenotypically distinct entities.
    Lin X; Lindner JL; Silverman JF; Liu Y
    Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):453-8. PubMed ID: 18665037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell kinetics of human epithelial ovarian cancers.
    Paradiso A; Silvestrini R; Daidone MG; Coltro Campi C; Grignolio E
    Basic Appl Histochem; 1986; 30(2):215-20. PubMed ID: 3017283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ovarian tumors. A review.
    Scully RE
    Am J Pathol; 1977 Jun; 87(3):686-720. PubMed ID: 194486
    [No Abstract]   [Full Text] [Related]  

  • 56. [Diagnostic problems of ovarian mucinous borderline tumors].
    Vereczkey I; Tóth E; Orosz Z
    Magy Onkol; 2009 Jun; 53(2):127-33. PubMed ID: 19581178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A patient with a noninvasive mucinous ovarian borderline tumor presenting with late pleural metastases.
    Simons M; Nagtegaal ID; Overbeek LI; Flucke U; Massuger LF; Bulten J
    Int J Gynecol Pathol; 2015 Mar; 34(2):143-50. PubMed ID: 25675183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Jejunal Metastasis Colliding With a Borderline Tumor in the Ovary: A Hitherto Unreported Eventuality.
    Piana S; Giunta A; Valli R
    Int J Surg Pathol; 2015 Oct; 23(7):567-70. PubMed ID: 25911566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Magnetic resonance imaging findings of mucinous borderline ovarian tumors: comparison of intestinal and endocervical subtypes.
    Woo S; Kim SH; Kim MA; Park IA; Lee MS; Kim SY; Cho JY
    Abdom Imaging; 2015 Aug; 40(6):1753-60. PubMed ID: 25504376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MRI appearances of mucinous borderline ovarian tumors: pathological correlation.
    Ma FH; Zhao SH; Qiang JW; Zhang GF; Wang XZ; Wang L
    J Magn Reson Imaging; 2014 Sep; 40(3):745-51. PubMed ID: 24395397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.